Small Molecules
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
52
NCT05833906
Safety, Tolerability, and Pharmacokinetic Evaluations of CKR-051 After Transdermal Administration in Healthy Male Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 25, 2023
Completion: Jan 8, 2024
Loading map...